12 2015 year China pharmaceutical development, Chinese medicine experts

Time: 2016-04-06

Source: China's traditional Chinese medicine

Author: Gao Xinjun zhu Lu air-conditioning

Report from our correspondent (reporter Gao Xinjun zhu Lu air-conditioning) 2015 year China pharmaceutical development, the general assembly held in the diaoyutai state guesthouse in Beijing on April 1, ding Ming, li 28 people such as awards, including national physician master ChaoEnXiang 12 research of traditional Chinese medicine experts, such as compared with the previous ratio increased significantly. Academician of the Chinese medicine institute director sang guowei, deputy chief of the state food and drug supervision and administration bureau Mr Sun attended the conference and prizes to the winners.

Jiangsu side of kang pharmaceutical co., LTD. Xiao Wei researcher, professor ChaoEnXiang china-japan friendship hospital, Beijing Oriental jia technology development co., LTD ChaoYan engineer was awarded a prize of innovative drugs; Longhua hospital affiliated to Shanghai university of traditional Chinese medicine, China academy of traditional Chinese medicine xiyuan hospital Li Yuehua yong-jun wang professor, director of the physician, the second hospital affiliated to zhejiang university of Chinese medicine xiao-lin shi, director of physicians, orthopedics hospital affiliated to guangzhou university of Chinese medicine of doctor of vice director of onelite won Kang Chen osteoporosis medical research award; Shaanxi provincial food and drug inspection hai-jing liu, director of the pharmacists, the shandong province food and drug inspection institute director xu lh pharmacist, a researcher at China's food and drug verification research institute Cheng Xianlong, xinjiang uygur autonomous region food and drug inspection sun deputy researcher by the food and drug quality detection technology; College of traditional Chinese medicine, southern medical university Luo Ren researcher for clinical medical research award.

Meeting by the Chinese medicine development, reward work committee and jointly organized by China society. Chinese medicine development is approved by the ministry of science and technology the first 26 national awards, one of the awards is established by social forces of national medicine. The award aims to reward medicine have made outstanding contributions or major science and technology achievements in the field of medical science and technology workers, promote the development of medicine.

Add: 2015 award-winning Chinese pharmaceutical development, traditional Chinese medicine experts

Innovative drug won - outstanding achievement award winners:

Xiao wei

Developed five series of 46 (class 2 new drugs 9) of new drug of TCM, including toxic heat ning injection for 2 kinds of traditional Chinese medicine (TCM), composed of artemisia annua,, gardenia, honeysuckle by essential oil distillation, countercurrent extraction, membrane separation and other modern extraction refining technology, which is approved after 2005 the first TCM injections, is also the first approved domestic using standard control of traditional Chinese medicine injection fingerprint, the structure composition of 85% or more, clinical effective rate of 96% above, and the incidence of adverse reactions was only 0.067%, significantly better than the similar traditional Chinese medicine (TCM) injections and medicine; Compared with chemical medicine, has the characteristics of fast antifebrile won't bounce back and no resistance; Authorized invention patent 18, China invention patent gold medal, the total sales income of 5.067 billion yuan, in 2014 sales revenue of 1.5 billion yuan. Have been listed in national influenza prevention and control of emergency stockpile drugs such as directory. Won the second prize of national scientific and technological progress are two (1, 2), and learn to level of science and technology progress award item 7 (1). 217, it has been approved for a patent for invention, published 442 academic theses, SCI 55, chief editor, deputy editor of book 5.

ChaoEn

Auspicious according to more than 50 years experience of clinical diagnosis and treatment, to break the traditional Chinese medicine cough etiology, pathogenesis, innovation for the first time put forward the \"wind\" cough disease, clarify \"wind evil committed airway twin acute lung,\" cause cough mechanism, to create \"breeze spasmolysis\" therapeutic agent. Airway hyperresponsiveness with modern medicine linked to cough mechanism, forming a complete set \"after a cold cough\", \"cough variant asthma\" in medicine, law, parties, medicine system. Guide to develop the domestic first proprietary Chinese medicine \"Sue yellow cough capsule\" for the treatment of the disease, was awarded the first prize for provincial level 1 item, and into the industry standard and teaching material. A patent for invention first inventor. National multicenter randomized positive drug control study found Sue yellow cough capsule is traditional Chinese medicine after a cold cough cough regimen for total effective rate increased by 11.66%, cough variant asthma increased by 17.85%; Get recognized experts at home and abroad. Sue yellow cough capsule to realize technology transfer. In 2014, sales reached 306 million yuan. Drive the farmers' income, obtain good social and economic benefits.

Classical yan

Complete Sue yellow cough capsule technology innovation, using the traditional extraction technology and modern production technology, the combination of process of purple Perilla leaf essential oils were extracted and the former hu and a - cyclodextrin inclusion, reduce the loss of volatile oil, improve the utilization ratio, to implement technology transfer and production development, increased the output and improve the quality. Sue yellow cough capsule is domestic treatment after a cold cough and cough variant asthma of proprietary Chinese medicine, fill the blank of the market.

Kang Chen osteoporosis medical research award - special award winner:

Yong-jun wang

Now work in longhua hospital affiliated to Shanghai university of traditional Chinese medicine, orthopedics. Long-term commitment to the prevention and treatment of the chronic disease of bones and muscles of traditional Chinese medicine clinical and basic research, in the field of prevention and treatment of bone metabolic disease of traditional Chinese medicine has made outstanding contributions. Participating in drafting and develop the TCM prevention and treatment of primary osteoporosis expert consensus (2015) is the first in the field of traditional Chinese medicine clinical guidelines in our country. As a key laboratory authorized by China's ministry of education (the physique theory and treatment), director of the national Chinese medicine clinical research base (bone degenerative diseases) project's chief scientist, national \"973\" plan project's chief scientist, is the winner of national outstanding youth science fund, the cheung kong scholars program distinguished professor of national ministry of education, has won the national advanced worker, national excellent science and technology workers, national pacesetter engineering national choice, \"ten thousand plan\" pacesetter engineering talents, etc. National prize for science and technology progress prize for 2 items.

Kang Chen osteoporosis medical research award - academic achievement award winners:

Li Yuehua

Professor, chief physician, doctoral tutor, China academy of traditional Chinese medicine xiyuan hospital of traditional Chinese medicine geriatrics national key disciplines, the world federation of Chinese medicine societies, vice chairman, the geriatric medicine branch of the Chinese society of traditional Chinese and western medicine combined with the vice chair of the health and health care branch. Formulated the kidney and spleen qi and individualization of traditional Chinese medicine in the treatment of osteoporosis treatment, national Chinese medicine geriatrics osteoporosis cooperation work, this plan in the national Chinese medicine cooperation promotion, and develop the clinical pathway. Formed a series of syndrome differentiation of traditional Chinese medicine in the treatment of osteoporosis, is developed in view of the kidney in patients with bone strength strong, strong bone pixu (spleen deficient) 1 # 2, and blood stasis of strength established 3 pharmacogenetics to traditional Chinese medicine preparation, and the meridian analgesic paste for external use of bone pain. Developed a national \"shu jin t2dm particles\". Ministry of science and technology, national natural science fund, the state administration of TCM scientific research fund of several; A combination of Chinese and western society of China science and technology progress award, etc.

Xiao-lin shi

Chief physician, professor, doctoral supervisor. The second clinical medical college of zhejiang university of TCM of Chinese and western medicine combined with the director of the teaching and research office of fractures, fractures of traditional Chinese medicine research institute of zhejiang province immunohistochemical lab director, fractures at the Chinese academy of combining traditional Chinese and western medicine professional committee, the Chinese society of gerontology osteoporosis committee vice chairman. The national natural fund evaluation experts, such as science and technology progress prize of the ministry of education for 2014. The state administration of traditional Chinese medicine \"11th five-year plan\" key ZhuanBing construction leader, \"twelfth five-year\" key subject construction.

Kang Chen osteoporosis medical research award - outstanding young scholar award winners:

Onelite now

Orthopedics hospital affiliated to guangzhou university of Chinese medicine orthopaedics. Long engaged in traditional Chinese medicine clinical and experimental research, the prevention and treatment of osteoporosis in the field of TCM prevention and treatment of osteoporosis, made a greater contribution. Participating in drafting and formulate the \"national administration of traditional Chinese medicine key specialty cooperative osteoporosis (bone impotent) diagnosis and treatment plan\" and \"osteoporosis clinical pathway of traditional Chinese medicine\", is the first in the field of TCM prevention and treatment of osteoporosis in TCM diagnosis and treatment schemes and clinical pathway of traditional Chinese medicine.

The food and drug quality inspection technology awards - outstanding achievement award winner:

Hai-jing liu

Level 1, pharmacists, director of the shaanxi provincial food and drug inspection bureau chief, enjoy special government allowances of the state council experts, part-time job, such as national pharmacopoeia committee. Successively presided over by participating countries, ministries and provincial scientific research topic more than 20 items, 6 national invention patents. Research and development characteristics of Chinese herbal medicine resources, has compiled \"taibai seven medicine research and application\", \"seven Chinese medicine such as book, set up in shaanxi province traditional Chinese medicine resources information database and represented by panlong seven planting base of Chinese herbal medicine, Chinese medicine efficacy composition screening platform and quality standard system research platform, for the Chinese herbal medicine industry development in shaanxi province has laid a solid foundation.

Xu lh

Incumbent shandong province, vice President of the food and drug inspection institute, director of pharmacists, ninth and tenth national pharmacopoeia committee, national Chinese medicine new drug evaluation experts, national protection of TCM variety appraisal committee member, etc. Employed for nearly 30 years, has been engaged in traditional Chinese medicine (TCM) in a line of food and drug inspection, quality analysis and the standard of research work. Lead the team to accomplish each drug registration, inspection, entrust the inspection, supervision to sample and emergency inspection tasks, such as the impact of Chinese traditional medicine for administrative law enforcement and ensure the safety of life of the people provides the reliable data to support. In 2010 ~ 2014 for \"orange pill series varieties\", \"Dan red injection\" five varieties of national drug evaluation sample task. Chinese medicines, and actively take the Chinese pharmacopoeia and national standards improve some varieties of standard drafting and review work, organization completed the \"traditional Chinese medicine preparation in shandong province\" \"standard of Chinese medicinal materials in shandong province\" 2012 version of the draft revision work, for national and local standards made outstanding contributions. Is given priority to with oneself done or participated in more than 10 scientific research projects, and won prizes at 10, the provincial science and technology progress award, 1 item 2014 participated in the \"twelfth five-year\" national science and technology major projects corpus \"traditional Chinese medicine quality and safety testing and risk control technology platform\".

Cheng Xianlong

, Ph.D., associate professor, now China's food and drug verification research institute is engaged in the quality control of TCM, the traditional Chinese medicine (TCM) test new technology and new method to research work. As magazines such as reviewing experts, Chinese modern medicine, Chinese medicine chemistry professional committee of China association of Chinese medicine, the national natural science fund project review expert, ministry of science and technology innovation \"safety testing and quality control of Chinese medicine\" core team members. Take a number of national drug standards drafting, revision, review, etc. Which establish tortoise-shell glue, antler glue, gelatin, medicinal materials, such as glue like varieties of specificity identification method and supplementary testing method, respectively adopted by \"the Chinese pharmacopoeia 2015 edition and the state food and drug supervision and administration bureau for approval. The work to fill the blank in the research of the glues specificity identification. More than 90 articles, of which more than 20 SCI articles, attend by 8. Related research won the fourth national conference on pharmaceutical analysis in 2014 excellent thesis first prize and so on.

The food and drug quality detection technology awards - outstanding young scholar award winners:

sun

The deputy director of the xinjiang uygur autonomous region food and drug inspection (temporary, the original unit of China's food and drug verification research institute), associate professor. Mainly engaged in the study of the quality standards of Chinese medicine, natural medicine and the harmful residue analysis. Drug analysis of the professional committee of China medicine institute and important fields of science and technology innovation team \"safety standards and quality of Chinese medicine research innovation team\" members. Completed the 2010 edition pharmacopeia frankincense quality standard drafting, participated in the 2015 edition pharmacopeia \"new traditional Chinese medicine extract technology in the application of traditional Chinese medicine quality control\". Frankincense in the research of quality standard income in China pharmacopoeia, 2010), the development of ion chromatography for determination of sulfur dioxide in Chinese traditional medicine has income \"Chinese pharmacopoeia\" 2015 version.

Clinical medical research award, outstanding achievement award winners:

Luo ren

Guangdong province name of traditional Chinese medicine, chief physician, doctoral supervisor, the state administration of traditional Chinese medicine the fifth batch of TCM doctor tutor. Engaged in the teaching of traditional Chinese medicine, medical treatment, scientific research work for 39 years, for kidney disease, gout, lupus erythematosus, kidney deficiency, sub-health has rich clinical experience, etc. Bear the national 863 program, and key projects of national natural science foundation of China - guangdong province joint, such as national natural science fund subject 16, application of traditional Chinese medicine \"cure not ill\", in 863 under a grant from the national high technology research and development projects, after years of meticulous research and become a sub-health the medicated wine - \"and with\" wine, suitable for a tired fatigue, insomnia, dizziness, tinnitus, etc have many dreams of sub-health population, health care and healthy people. For sub-health are the four most common syndrome, namely, fatigue, constipation, fatigue and throat uncomfortable symptom, such as research and development of 4 kinds of herbal tea series, 2 national invention patents. Developed the prevention and treatment of sub-health fatigue of traditional Chinese medicine compound weikang granule, nanfang hospital, southern medical university hospital preparations, has good clinical application.